UBS Analysts Give Pfizer (NYSE:PFE) a $40.00 Price Target

Joanna Estrada
December 15, 2017

The Holderness Investments Company holds 70,882 shares with $2.38 million value, down from 86,462 last quarter. Novo Nordisk A/S Spons Adr now has $126.83B valuation.

Pfizer Inc. (NYSE:PFE) gained 0.16 Percent and closed its previous trading session at $36.64. About 236,938 shares traded. (NYSE:PFE) were released by: Reuters.com and their article: "Pfizer's Xeljanz gets FDA nod as joint disease treatment" published on December 15, 2017 as well as Twst.com's news article titled: "Pfizer Inc.: FDA Approves New Pfizer Biosimilar" with publication date: December 13, 2017. It has underperformed by 9.89% the S&P500.

Sabal Trust Co increased Pfizer Inc (PFE) stake by 6.1% reported in 2017Q2 SEC filing. Roundview Capital Llc bought 10,543 shares as the company's stock declined 3.45% while stock markets rallied. The rating was maintained by Robert W. Baird on Monday, December 4 with "Hold". Intll Invsts has 1.69% invested in Pfizer Inc.

The stock increased 1.22% or GBX 0.15 during the last trading session, reaching GBX 12.4. About 14.79M shares traded. It has underperformed by 19.46% the S&P500.

Among 10 analysts covering Whirlpool (NYSE:WHR), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 100% are positive. Vetr upgraded shares of Pfizer from a "hold" rating to a "buy" rating and set a $38.82 price objective on the stock in a research report on Thursday, November 23rd. (NYSE:PFE). 32,696 were accumulated by Crossvault Cap Management Ltd Co. As per Wednesday, November 1, the company rating was maintained by UBS. The stock of Accenture plc (NYSE:ACN) has "Buy" rating given on Friday, October 16 by Cantor Fitzgerald. The stock has "Overweight" rating by JP Morgan on Thursday, April 7. The firm has "Buy" rating by Stifel Nicolaus given on Thursday, September 28. As per Monday, October 31, the company rating was downgraded by DNB Markets. BMO Capital Markets set a $39.00 target price on Pfizer and gave the company a "buy" rating in a research report on Friday, December 8th. About 1.14M shares traded or 7.07% up from the average. It also reduced its holding in Citigroup Inc (NYSE:C) by 244,583 shares in the quarter, leaving it with 4.97 million shares, and cut its stake in Morgan Stanley (NYSE:MS). Ci Global Invests Incorporated invested in 0.42% or 665,428 shares. NVO's profit will be $1.36B for 23.33 P/E if the $0.56 EPS becomes a reality.

Private Wealth Partners Llc, which manages about $794.14 million and $460.52 million US Long portfolio, upped its stake in Apple Inc (NASDAQ:AAPL) by 3,371 shares to 182,207 shares, valued at $26.24 million in 2017Q2, according to the filing. (NYSE:PFE) on Thursday, August 31. Blackrock Inc (NYSE:BLK) was raised too.

Analysts await Magna International Inc.

Several research analysts have weighed in on PFE shares. The biopharmaceutical company reported $0.67 earnings per share for the quarter, beating analysts' consensus estimates of $0.65 by $0.02. After $0.45 actual earnings per share reported by ProAssurance Corporation for the previous quarter, Wall Street now forecasts 42.22% EPS growth. Therefore 69% are positive. Pfizer had 66 analyst reports since July 29, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with "Buy" rating and $37.0 target in Tuesday, September 5 report. The rating was maintained by Piper Jaffray on Wednesday, August 2 with "Buy". The rating was downgraded by Credit Suisse to "Neutral" on Thursday, July 20. Finally, Deutsche Bank set a $38.00 price objective on Pfizer and gave the company a buy rating in a report on Wednesday, October 11th.

Receive News & Ratings for Pfizer Inc. (NYSE:PFE) earned "Market Perform" rating by Leerink Swann on Monday, May 2. Berenberg initiated Pfizer Inc. (NYSE:PFE) on Tuesday, June 14 with "Buy" rating. (NYSE:PFE) earned "Neutral" rating by Societe Generale on Friday, March 24. The firm has "Outperform" rating by Cowen & Co given on Tuesday, October 20.

Investors sentiment decreased to 0.94 in 2017 Q2. Its up 0.02, from 0.94 in 2017Q1. It fall, as 58 investors sold PFE shares while 716 reduced holdings. 112 funds opened positions while 612 raised stakes. Hgk Asset Management Inc owns 271,419 shares. Wealthfront reported 0.05% of its portfolio in Pfizer Inc. (NYSE:PFE). Driehaus Limited Liability Company holds 15,097 shares. (NYSE:PFE). Wfg Advsr LP invested in 55,528 shares or 0.42% of the stock. (NYSE:PFE) for 41,435 shares. Moreover, Bridges Counsel has 0.67% invested in Pfizer Inc. Reduces Position in Pfizer Inc. (NYSE:PFE) for 39,232 shares. Matrix Asset Advsrs New York invested in 235,711 shares. Cheviot Value Mgmt Limited reported 4.41% stake. Chilton Ltd Liability has 6,650 shares. Glenmede Co Na owns 3.23M shares or 0.53% of their U.S. portfolio. Northstar Group Inc. now owns 8,602 shares of the biopharmaceutical company's stock valued at $289,000 after purchasing an additional 35 shares during the period. (NYSE:PFE). West Virginia-based United Comml Bank Inc has invested 0.46% in Pfizer Inc. 91,920 are owned by First City Capital Mgmt.

Since August 4, 2017, it had 0 insider buys, and 8 sales for $15.81 million activity. The legal version of this article can be accessed at https://weekherald.com/2017/12/14/apriem-advisors-sells-4494-shares-of-pfizer-inc-pfe.html. The shares were sold at an average price of $35.30, for a total transaction of $518,910.00. $1.34M worth of Pfizer Inc. SUSMAN SALLY had sold 38,230 shares worth $1.34M on Tuesday, September 12. 96,950 shares valued at $3.30 million were sold by READ IAN C on Friday, August 4.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER